Yelin Lapidot Holdings Management Ltd. Compugen LTD Transaction History
Yelin Lapidot Holdings Management Ltd.
- $574 Billion
- Q4 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Compugen LTD stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 318,852 shares of CGEN stock, worth $542,048. This represents 0.08% of its overall portfolio holdings.
Number of Shares
318,852
Previous 318,852
-0.0%
Holding current value
$542,048
Previous $577 Million
15.47%
% of portfolio
0.08%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
80Shares Held
13.4MCall Options Held
44.9KPut Options Held
8.1K-
Silverarc Capital Management, LLC1.62MShares$2.76 Million0.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$2.17 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$1.86 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.73 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$1.68 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $147M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...